Viewing Study NCT03066427


Ignite Creation Date: 2025-12-25 @ 5:06 AM
Ignite Modification Date: 2026-04-08 @ 8:19 AM
Study NCT ID: NCT03066427
Status: COMPLETED
Last Update Posted: 2020-11-13
First Post: 2017-02-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study to Evaluate Efficacy and Safety of Sunitinib in Renal Cell Carcinoma Progressed to 1L Immunotherapy Treatment.
Sponsor: Spanish Oncology Genito-Urinary Group
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module